Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Med12l Activators

Med12l Activators would be classified as a group of substances that enhance the activity of the protein encoded by the MED12L gene. MED12L is a paralog of MED12, both of which are components of the mediator complex - a multi-protein assembly that is crucial for the transcriptional regulation of nearly all RNA polymerase II-dependent genes. Activators of Med12l would therefore be expected to facilitate or increase its role in transcriptional regulation. The precise mechanism of action for these activators could involve direct binding to the Med12l protein, modifying its interaction with other mediator complex components or associated transcription factors, or influencing post-translational modifications that regulate Med12l function. The chemical structures of these activators could be diverse, potentially including small molecules, peptides, or other biologically active agents that can engage with the Med12l protein in a cell.

The research aimed at identifying and characterizing Med12l activators would engage a variety of scientific techniques. Initial discovery may involve the use of high-throughput screening to assess a large library of compounds for their ability to modulate Med12l activity, with subsequent assays confirming the specificity and potency of these interactions. Verification of activity would require robust biochemical assays, possibly leveraging reporter genes or direct measures of transcriptional activity in response to these compounds. Following the identification of putative activators, detailed mechanistic studies would be necessary to understand how they influence Med12l and the mediator complex. Such studies might include co-immunoprecipitation and mass spectrometry to identify interaction networks, chromatin immunoprecipitation followed by sequencing (ChIP-seq) to determine the impact on genome-wide transcriptional profiles, and site-directed mutagenesis to map the activator binding sites. These investigations would provide valuable insights into the fundamental regulation of gene expression by the mediator complex and the specific role Med12l plays within this essential cellular process.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

As a DNA methyltransferase inhibitor, this compound may alter methylation patterns, potentially affecting MED12L expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Vorinostat is a histone deacetylase inhibitor, which may increase transcription of various genes, potentially including MED12L.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid modulates gene expression through nuclear receptors, which could lead to changes in MED12L expression.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

This polyphenol can modulate epigenetic marks, possibly influencing MED12L expression by remodeling chromatin.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein affects gene expression by acting as a tyrosine kinase inhibitor, potentially altering MED12L expression levels.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

RG108 is a DNA methyltransferase inhibitor that could lead to demethylation and activation of certain genes, including possibly MED12L.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

Sulforaphane affects histone deacetylase activity, which could alter the expression of various genes, such as MED12L.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol has been shown to modulate sirtuin activity and affect gene expression, potentially influencing MED12L levels.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin can modulate transcription factors and chromatin structure, which may impact MED12L expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

This compound binds to DNA and can interfere with transcription factor binding, potentially affecting MED12L expression.